Faculty Directory Dr. Subhamoy Banerjee
Dr. Subhamoy Banerjee

Dr. Subhamoy Banerjee

Associate Professor

Academic Information

B.Tech in Biotechnology (WBUT)


M.Tech in Biotechnology (RGPV, Bhopal)


PhD in Biotechnology (IIT Guwahati)


Postdoc (IIT Delhi)

Research Areas

Research Interests

Pathway crosstalk, shared gene hypothesis, network biology, viral genomics

Courses Taught

Biology, Economics and entrepreneurship, Sustainability

Positions Held

Co-convenor ICCAES (2022-2026), SPOC Economics, Finance and Venture Design (2024-2026)

Publications


  1. Eco-Savvy Solutions: A Deep Dive into Modern Bioremediation Techniques for Soil and Sediment Cleanup
    S Sarkar, T Basu, S Banerjee, R Mukherjee, Bioremediation of Petroleum Contaminated Soil and Sediment, 319-342


  2. Nanobioremediation technologies for environmental cleanup: Principles, current advances and applications
    S Banerjee, A Ray, T De, R Mukherjee, EPJ Web of Conferences 370, 01026


  3. Biological waste-derived carbon dots and their applications
    S Banerjee, R Mukherjee, Waste-Derived Carbon Nanostructures: Synthesis and Applications, 107-128


  4. Applying systems biology frameworks in the investigation of chronic infectious diseases
    S Banerjee, Advancing Science and Innovation in Healthcare Research, 39-50


  5. An Overview of Bioremediation Using Bioadsorbents
    S Sarkar, T Basu, S Banerjee, R Mukherjee, Biodegradation of Toxic and Hazardous Chemicals, 57-70


  6. Two-dimensional material-based novel drug delivery system
    S Banerjee, R Mukherjee, Two-Dimensional Hybrid Composites: Synthesis, Properties and Applications


  7. Role of Cannabinoids in the Regulation of Amyotrophic Lateral Sclerosis (ALS)
    A Muthuramalingam, AK Pandurangan, S Banerjee, Medical Cannabis and the Effects of Cannabinoids on Fighting Cancer, Multiple Sclerosis, Epilepsy, Parkinson's, and Other Neurodegenerative Diseases


  8. Understanding the clinical link between fasting and response to cancer therapy
    IB Ishthiaq, M Waseem, S Banerjee, Current Pharmacology Reports 8 (4), 290-299


  9. Network pharmacology approach to delineate relationship between type 2 diabetes mellitus and triple negative breast cancer
    A Akbar, S Banerjee, International Journal of Chemical and Environmental Sciences 3 (4), 20-29


  10. Bio imaging applications of noble metal nanoclusters
    S Banerjee, International Journal of Chemical and Environmental Sciences 3 (3), 37-42


  11. Cellular and Molecular Machinery of Neuropathic Pain: an Emerging Insight
    Shabnam Ameenudeen, Mohd. Kashif, Subhamoy Banerjee, Hemalatha Srinivasan, Pandurangan Ashok Kumar, Mohammad Waseem, Current Pharmacology Reports, 10.1007/s40495-022-00294-9


  12. Calcium calmodulin-dependent protein kinase as a potential drug target
    S Banerjee, MKA Khan, PROTEIN KINASE INHIBITORS From Discovery to Therapeutics 1, 657-670


  13. Network medicine-based analysis of association between gynecological cancers and metabolic and hormonal disorders
    AL Salaudeen, S Banerjee, Applied biochemistry and biotechnology 194 (1), 323-338


  14. Herbal Based Drug Discovery for Skin and Surgical Infectious Diseases
    S Afreen, W Syed, S Banerjee, Biopharmacological Activities of Medicinal Plants and Bioactive Compounds


  15. An overview of bioinformatics resources for SNP analysis
    S Sukumar, A Krishnan, S Banerjee, Advances in bioinformatics, 113-135


  16. Computational Evolutionary Biology
    S Banerjee, Advances in Bioinformatics, 83-100


  17. In silico Screening and Identification of Natural Compound Sophoraflavanone G as Potential Human Sodium-Glucose Cotransporter 2 Inhibitor
    Wasimuddin S,Irfan N,S Banerjee, Biointerface Research in Applied Chemistry 11 (6), 14173-14184


  18. Nanoparticle-Mediated Therapeutic Approach for Ulcerative Colitis Treatment
    S Banerjee,Diagnostic and Treatment Methods for Ulcerative Colitis and Colitis-Associated Cancer


  19. Nanoparticle-Based Delivery of Phytochemical Compounds Against Major Maladies: Cancer, Diabetes, and Cardiovascular Disease
    S Banerjee, Plant-derived Bioactives Production, Properties and Therapeutic Applications


  20. Curcumin nanoformulation in glioblastoma therapy
    S Banerjee, Phytocompounds: Sources and Bioactivities 1, 35-56


  21. DNA-templated single thermal cycle based synthesis of highly luminescent Au nanoclusters for probing gene expression
    AK Sahoo, SK Sailapu, D Dutta, S Banerjee, SS Ghosh, A Chattopadhyay, ACS Sustainable Chemistry & Engineering 6 (2), 2142-2151


  22. Silver nanocluster embedded composite nanoparticles for targeted prodrug delivery in cancer theranostics
    AK Sahoo, U Goswami, D Dutta, S Banerjee, A Chattopadhyay, SS Ghosh, ACS Biomaterials Science & Engineering 2 (8), 1395-1402


  23. Brain machine interface in biomedical application
    S Banerjee, J Gomes, Cutting Edge 5 (5), 16-20


  24. Recombinant IκBα-loaded curcumin nanoparticles for improved cancer therapeutics
    S Banerjee, AK Sahoo, A Chattopadhyay, SS Ghosh, Nanotechnology 25 (34), 345102


  25. Characterization, mechanism of anticoagulant action, and assessment of therapeutic potential of a fibrinolytic serine protease (Brevithrombolase) purified from Brevibacillus …
    Sourav Majumdar, Biplob Sarmah, Debananda Gogoi, Subhamoy Banerjee, Siddhartha S Ghosh, Subham Banerjee, Pronobesh Chattopadhyay, Ashis K Mukherjee, Biochimie 103, 50-60


  26. Folic acid conjugated-bio polymeric nanocarriers: Synthesis, characterization and in vitro delivery of prodrug converting enzyme
    VK Yata, S Banerjee, SS Ghosh, Advanced science, engineering and medicine 6 (4), 388-392


  27. Simultaneous RGB emitting Au nanoclusters in chitosan nanoparticles for anticancer gene theranostics
    AK Sahoo, S Banerjee, SS Ghosh, A Chattopadhyay, ACS Applied Materials & Interfaces 6 (1), 712-724


  28. Chemosensitization of IκBα-overexpressing glioblastoma towards anti-cancer agents
    S Banerjee, AK Sahoo, A Chattopadhyay, SS Ghosh, RSC advances 4 (74), 39257-39267


  29. Hydrogel nanocarrier encapsulated recombinant IκBα as a novel anticancer protein therapeutics
    S Banerjee, AK Sahoo, A Chattopadhyay, SS Ghosh, RSC advances 3 (33), 14123-14131


  30. Direct CIII–HflB interaction is responsible for the inhibition of the HflB (FtsH)‐mediated proteolysis of Escherichia coliσ32 by λCIII
    S Halder, S Banerjee, P Parrack, The FEBS Journal 275 (19), 4767-4772